A Randomized, Placebo-Controlled Phase II Study Evaluating the Reduction of Neutropenia and Febrile Neutropenia in Patients With Colorectal Cancer Receiving Pegfilgrastim With Every-2-Week Chemotherapy

Joel Randolph Hecht, Madhavan V. Pillai, Russell Gollard et al. · Clinical Colorectal Cancer · 2010

Cited by 72 works. doi:10.3816/ccc.2010.n.013

Authors

References